Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q3 2023 Earnings Call Transcript November 8, 2023 Amicus Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.08. Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Third Quarter 2023 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder, this conference is being […]

Related Keywords

United Kingdom ,Germany ,Austria ,United States ,Jeff Castelli ,Simon Harford ,Bradley Campbell ,Chief Development Officer ,Chief Financial Officer ,Highest Alcohol Consumption ,Gins Under ,Amicus Therapeutics ,Xchange Rates ,Chief Executive Officer ,Forward Looking Statements ,Andrew Faughnan ,